John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$297M |
| 2 |
Bank of America
BAC
|
+$249M |
| 3 |
Oracle
ORCL
|
+$247M |
| 4 |
Microsoft
MSFT
|
+$246M |
| 5 |
Snap
SNAP
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$260M |
| 2 |
Merck
MRK
|
+$260M |
| 3 |
S&P Global
SPGI
|
+$233M |
| 4 |
Occidental Petroleum
OXY
|
+$221M |
| 5 |
Walmart Inc
WMT
|
+$211M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.21% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 11.06% |
| 4 | Industrials | 10.41% |
| 5 | Consumer Discretionary | 7.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Acadia Pharmaceuticals
ACAD
$5.27B
| $828K | ﹤0.01% |
58,800
-181,671
| -76% | -$3.39M |
|
1602
Laureate Education
LAUR
$5.27B
| $828K | ﹤0.01% |
71,600
-167,534
| -70% | -$1.99M |
|
1603
ARS Pharmaceuticals
SPRY
$560M
| $820K | ﹤0.01% |
193,500
-207,676
| -52% | -$724K |
|
1604
Brady Corp
BRC
$4.39B
| $818K | ﹤0.01% |
+17,309
| New | +$796K |
|
1605
Equity Bancshares
EQBK
$1.02B
| $817K | ﹤0.01% |
28,006
+1,638
| +6% | +$51.3K |
|
1606
CorMedix
CRMD
$663M
| $816K | ﹤0.01% |
202,962
+131,036
| +182% | +$487K |
|
1607
Pangaea Logistics
PANL
$545M
| $811K | ﹤0.01% |
159,651
+77,246
| +94% | +$423K |
|
1608
MetroCity Bankshares
MCBS
$1.01B
| $805K | ﹤0.01% |
39,615
+18,419
| +87% | +$381K |
|
1609
LiveRamp
RAMP
$2.29B
| $804K | ﹤0.01% |
31,158
-3,696
| -11% | -$110K |
|
|
THR
1610
DELISTED
Thermon Group Holdings
THR
| $804K | ﹤0.01% |
57,238
-8,135
| -12% | -$126K |
|
1611
Titan International
TWI
$463M
| $803K | ﹤0.01% |
53,200
-4,876
| -8% | -$78.7K |
|
1612
Porch Group
PRCH
$1.97B
| $802K | ﹤0.01% |
+313,202
| New | +$1.3M |
|
1613
RLX Technology
RLX
$2.19B
| $800K | ﹤0.01% |
375,663
-2,495,457
| -87% | -$5.02M |
|
1614
WaFd
WAFD
$2.68B
| $800K | ﹤0.01% |
+26,648
| New | +$837K |
|
1615
Harrow
HROW
$1.55B
| $799K | ﹤0.01% |
109,750
+31,193
| +40% | +$210K |
|
1616
Ducommun
DCO
$2.75B
| $798K | ﹤0.01% |
18,530
+2,367
| +15% | +$113K |
|
1617
Anavex Life Sciences
AVXL
$326M
| $796K | ﹤0.01% |
79,570
-37,263
| -32% | -$353K |
|
1618
Silvercrest Asset Management
SAMG
$78.1M
| $795K | ﹤0.01% |
48,458
+5,279
| +12% | +$105K |
|
1619
PUT
Lumentum
LITE
$78.1B
| $794K | ﹤0.01% |
10,000
| – | – |
|
|
NPKI
1620
NPK International
NPKI
$1.12B
| $794K | ﹤0.01% |
256,997
-177,533
| -41% | -$680K |
|
1621
Merchants Bancorp
MBIN
$2.45B
| $793K | ﹤0.01% |
34,963
+17,114
| +96% | +$417K |
|
|
KNBE
1622
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
| $793K | ﹤0.01% |
50,800
+2,500
| +5% | +$48.9K |
|
1623
Preformed Line Products
PLPC
$2.01B
| $790K | ﹤0.01% |
12,848
+6,015
| +88% | +$372K |
|
|
BFX
1624
DELISTED
BowFlex Inc.
BFX
| $786K | ﹤0.01% |
449,021
+400,834
| +832% | +$1.11M |
|
1625
Atea Pharmaceuticals
AVIR
$436M
| $785K | ﹤0.01% |
110,517
-491,485
| -82% | -$3.36M |
|
Similar funds
John Overdeck's Q2 2022 Portfolio in Review
As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Merck, an estimated $260M trimmed.
- John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
- John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
- John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
- John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
- John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
- John Overdeck opened 628 new positions and closed 730 in Q2 2022.
- John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.
Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.